These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10398607)

  • 1. Radioiodine and thyroid eye disease.
    Walsh JP; Dayan CM; Potts MJ
    BMJ; 1999 Jul; 319(7202):68-9. PubMed ID: 10398607
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioiodine and thyroid eye disease. Routine steroid prophylaxis is not yet justified.
    Ahlquist J
    BMJ; 1999 Oct; 319(7217):1133-4. PubMed ID: 10531117
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term effect of radioiodine therapy on the thyroid antibodies in the patients of Graves' disease with postirradiation hypothyroidism.
    Chang TC; Chang CC; Chen FW; Liaw KY
    Taiwan Yi Xue Hui Za Zhi; 1986 Dec; 85(12):1177-82. PubMed ID: 2880926
    [No Abstract]   [Full Text] [Related]  

  • 4. Radioiodine and thyroid-associated ophthalmopathy: from the myth to the reality.
    Beckers C
    J Endocrinol Invest; 1999 Oct; 22(9):705-7. PubMed ID: 10595836
    [No Abstract]   [Full Text] [Related]  

  • 5. Early complications of radioiodine treatment for hyperthyroidism.
    Segers O; Musch W; Schoors DF
    Acta Clin Belg; 1993; 48(4):253-8. PubMed ID: 8212977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre.
    Chiovato L; Santini F; Vitti P; Bendinelli G; Pinchera A
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):803-6. PubMed ID: 8033373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Graves' disease following radioiodine treatment for autonomously functioning thyroid adenoma: case report.
    Martinko J; Cigrovski-Berković M; Becejac B; Solter D; Solter M
    Acta Clin Croat; 2011 Dec; 50(4):615-7. PubMed ID: 22649896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in thyroid eye disease.
    Cawood T; Moriarty P; O'Shea D
    BMJ; 2004 Aug; 329(7462):385-90. PubMed ID: 15310608
    [No Abstract]   [Full Text] [Related]  

  • 9. Graves disease induced by radioactive iodine.
    Kay TW; Heyma P; Harrison LC; Martin FI
    Ann Intern Med; 1987 Dec; 107(6):857-8. PubMed ID: 3688680
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of radioiodine therapy on the presence of autoantibodies against human thyroid and eye muscle fractions.
    Molnár I; Balázs C
    J Endocrinol Invest; 2000 Jan; 23(1):63-4. PubMed ID: 10698054
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of Graves' hyperthyroidism after radioiodine treatment for a toxic nodule: is the hyperthyroidism always triggered by 1311 therapy?
    Niepomniszcze H; Pitoia F; Goodall C; Manavela M; Bruno OD
    Thyroid; 2001 Oct; 11(10):991. PubMed ID: 11716050
    [No Abstract]   [Full Text] [Related]  

  • 12. Appearance of Graves'-like disease after radioiodine therapy for toxic as well as non-toxic multinodular goitre.
    Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):129-30. PubMed ID: 7641405
    [No Abstract]   [Full Text] [Related]  

  • 13. Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma.
    Regalbuto C; Salamone S; Scollo C; Vigneri R; Pezzino V
    J Endocrinol Invest; 1999 Feb; 22(2):147-50. PubMed ID: 10195384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease.
    Schmidt M; Gorbauch E; Dietlein M; Faust M; Stützer H; Eschner W; Theissen P; Schicha H
    Thyroid; 2006 Mar; 16(3):281-8. PubMed ID: 16571091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodine therapy versus antithyroid medications for Graves' disease.
    Ma C; Xie J; Wang H; Li J; Chen S
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD010094. PubMed ID: 26891370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of hypothyroidism after radioiodine treatment for Graves disease.
    Rosado M; Borrego LC; Paniagua ME
    Bol Asoc Med P R; 1983 Apr; 75(4):167-9. PubMed ID: 6575789
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyroid eye disease associated with athyria.
    Rogers PB; Gupta N; Rose GE; Plowman PN
    Br J Ophthalmol; 2000 Apr; 84(4):439. PubMed ID: 10777282
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in the properties of the thyrotropin receptor antibody in patients with Graves' disease after radioiodine treatment.
    Cho BY; Shong YK; Chung JK; Lee MC; Lee HK; Koh CS; Min HK
    Thyroidology; 1989 Dec; 1(3):109-14. PubMed ID: 2484872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic controversies. Radioiodine therapy does not aggravate Graves' ophthalmopathy.
    Gorman CA
    J Clin Endocrinol Metab; 1995 Feb; 80(2):340-2. PubMed ID: 7852485
    [No Abstract]   [Full Text] [Related]  

  • 20. [The etiology of Graves' disease--current state of knowledge].
    Hen K; Czarnywojtek A; Florek E; Warmuz-Stangierska I; Ruchała M
    Przegl Lek; 2012; 69(10):1132-4. PubMed ID: 23421108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.